ReviewCancer cell international2026
Innovative approaches in the treatment of hematologic malignancies: the role of CRISPR-engineered microbiomes along the gut-immune axis in immunotherapy development.
Chou-Yi Hsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.